Hengliang Shi

10PUBLICATIONS
11CO-AUTHORS
Particle physicsPredictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 18, 2024
NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression.

Zhiyi Liu, Qinghe Hu, Qing Luo

|Jul 29, 2024
Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer.

Zhiyi Liu, Qinghe Hu, Kuan Cao

|Jun 06, 2024
SIAH2 suppresses c-JUN pathway by promoting the polyubiquitination and degradation of HBx in hepatocellular carcinoma.

Qinghe Hu, Zhiyi Liu, Yao Liu

|Apr 28, 2023
Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer.

Bei Zuo, Tao Li, Xiaoyun Liu

|Apr 11, 2023
SIAH1/CTR9 axis promotes the epithelial-mesenchymal transition of hepatocellular carcinoma.

Zhiyi Liu, Pengchao Luo, Kuan Cao

|Oct 14, 2022
H3F3A K27M Mutation Promotes the Infiltrative Growth of High-Grade Glioma in Adults by Activating β-Catenin/USP1 Signaling.

Zhiyuan Sun, Yufu Zhu, Xia Feng

Pageof 2

Frequent Collaborators

1 joint publications

Bei Zuo

1 joint publications

Tao Li

1 joint publications

Xiaoyun Liu

1 joint publications

Shuling Wang